HomeComparePROS vs JNJ

PROS vs JNJ: Dividend Comparison 2026

PROS yields 15.56% · JNJ yields 2.14%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 PROS wins by $25.0K in total portfolio value
10 years
PROS
PROS
● Live price
15.56%
Share price
$12.85
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$55.4K
Annual income
$4,062.78
Full PROS calculator →
JNJ
Johnson & Johnson
● Live price
2.14%
Share price
$242.49
Annual div
$5.20
5Y div CAGR
28%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$30.5K
Annual income
$4,749.88
Full JNJ calculator →

Portfolio growth — PROS vs JNJ

📍 PROS pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodPROSJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, PROS + JNJ cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
PROS pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

PROS
Annual income on $10K today (after 15% tax)
$1,322.96/yr
After 10yr DRIP, annual income (after tax)
$3,453.36/yr
JNJ
Annual income on $10K today (after 15% tax)
$182.28/yr
After 10yr DRIP, annual income (after tax)
$4,037.40/yr
At 15% tax rate, JNJ beats the other by $584.03/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of PROS + JNJ for your $10,000?

PROS: 50%JNJ: 50%
100% JNJ50/50100% PROS
Portfolio after 10yr
$42.9K
Annual income
$4,406.33/yr
Blended yield
10.26%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

PROS
Analyst Ratings
4
Buy
2
Hold
Consensus: Buy
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
-5.7% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

PROS buys
0
JNJ buys
0
No recent congressional trades found for PROS or JNJ in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricPROSJNJ
Forward yield15.56%2.14%
Annual dividend / share$2.00$5.20
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%28%
Portfolio after 10y$55.4K$30.5K
Annual income after 10y$4,062.78$4,749.88
Total dividends collected$27.4K$15.6K
Payment frequencyquarterlyquarterly
SectorStockHealthcare
Analyst consensusBuyBuy

Year-by-year: PROS vs JNJ ($10,000, DRIP)

YearPROS PortfolioPROS Income/yrJNJ PortfolioJNJ Income/yrGap
1← crossover$12,256$1,556.42$10,594$274.49+$1.7KPROS
2$14,897$1,782.82$11,294$360.69+$3.6KPROS
3$17,965$2,025.18$12,133$476.91+$5.8KPROS
4$21,505$2,282.48$13,156$635.42+$8.3KPROS
5$25,564$2,553.50$14,432$854.61+$11.1KPROS
6$30,190$2,836.86$16,056$1,162.76+$14.1KPROS
7$35,435$3,131.07$18,175$1,604.53+$17.3KPROS
8$41,350$3,434.56$21,009$2,252.68+$20.3KPROS
9$47,990$3,745.68$24,911$3,229.73+$23.1KPROS
10$55,412$4,062.78$30,458$4,749.88+$25.0KPROS

PROS vs JNJ: Complete Analysis 2026

PROSStock

ProSight Global, Inc. provides property and casualty insurance services. The company is headquartered in Morristown, New Jersey and currently employs 392 full-time employees. The firm writes insurance coverage in seven customer segments: Media and Entertainment, Real Estate, Professional Services, Transportation, Construction, Consumer Services, and Marine and Energy. Its Media and Entertainment customer segment offers solutions to customers engaged directly in the film production, live media and sports sectors. Its Real Estate customer segment is designed to support the ownership and/or management of buildings, multifamily residential properties or mixed use urban buildings. The company offers professional liability and commercial insurance products to customers that sell professional advice or services. The company Transportation customer segment writes a variety of property and casualty coverage for its Transportation customers. The company offers property, general liability, workers’ compensation, commercial auto and excess coverage to its Construction customers.

Full PROS Calculator →

JNJHealthcare

Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.

Full JNJ Calculator →
📬

Get this PROS vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

PROS vs SCHDPROS vs JEPIPROS vs OPROS vs KOPROS vs MAINPROS vs ABBVPROS vs MRKPROS vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.